John L Marshall1. Show Affiliations » 1. Division ofHematology/Oncology, Georgetown University Medical Center, Washington, DC, USA.
Abstract
Entities: Chemical Disease
Mesh： See more » Adenocarcinoma/drug therapyAdenocarcinoma/secondaryAdenocarcinoma/surgeryAgedAngiogenesis Inhibitors/therapeutic useAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, HumanizedAntineoplastic Combined Chemotherapy Protocols/administration & dosageAntineoplastic Combined Chemotherapy Protocols/therapeutic useBevacizumabCamptothecin/administration & dosageCamptothecin/analogs & derivativesCetuximabColonic Neoplasms/drug therapyColonic Neoplasms/pathologyColonic Neoplasms/surgeryFluorouracil/administration & dosageHumansLeucovorin/administration & dosageLung Neoplasms/drug therapyLung Neoplasms/secondaryMaleMiddle AgedOrganoplatinum Compounds/administration & dosageReceptors, Cell Surface/bloodTreatment Outcome
Substances： See more » Angiogenesis InhibitorsAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedOrganoplatinum CompoundsReceptors, Cell Surfacecarcinoembryonic antigen binding protein, humanBevacizumabCetuximabLeucovorinFluorouracilCamptothecin
Year: 2007 PMID： 17491585
Source DB: PubMed Journal: Clin Adv Hematol Oncol ISSN： 1543-0790